Live Quotes / SUNPHARMA.NS / Valuation
Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) — Valuation
Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) valuation snapshot: fair value range, forward P/E, trailing P/E, dividend yield and upside potential. Assess whether Sun Pharma stock is undervalued or overvalued.
Sun Pharma is India's largest pharma company with US generics, branded formulations and specialty products.
About Sun Pharmaceutical Industries Limited Valuation
Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) trades on the NSE in India (NSE/BSE). This page provides a valuation view including valuation, fair value, intrinsic value signals, computed in real time from live market data. Data updates every 30 seconds. Currency shown in ₹ (INR).
Frequently Asked Questions — Sun Pharma stock
What drives Sun Pharma's revenue?
US specialty product launches (Ilumya, Winlevi, Cequa), India branded generics growth and EBITDA margin improvement are the key Sun Pharma metrics.
How do I value Sun Pharma?
Forward P/E relative to Dr. Reddy's, Cipla and the Nifty Pharma index is the standard benchmark for Sun Pharma valuation.